Gentian Diagnostics ASA (OSL:GENT)
Norway · Delayed Price · Currency is NOK 39.70
-0.30 (-0.75%)
Aug 4, 2026, 3:32 PM CET
Gentian Diagnostics ASA Balance Sheet
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 79.34 | 105.93 | 84.74 | 87.64 | 81.6 | 114.94 |
Cash & Short-Term Investments | 79.34 | 105.93 | 84.74 | 87.64 | 81.6 | 114.94 |
Cash Growth | -1.13% | 25.01% | -3.31% | 7.41% | -29.00% | -27.25% |
Accounts Receivable | 45.36 | 24.27 | 31.28 | 16.98 | 19.19 | 22.58 |
Inventory | 53.49 | 54.14 | 45.94 | 37.12 | 38.54 | 29.78 |
Total Current Assets | 178.19 | 184.34 | 161.96 | 141.73 | 139.33 | 167.3 |
Net Property, Plant & Equipment | 22.87 | 25.55 | 14.02 | 18.05 | 21.64 | 19.49 |
Other Intangible Assets | 4.53 | 35.83 | 28.46 | 21.16 | 26.82 | 25.01 |
Long-Term Investments | - | - | - | 0.1 | - | - |
Other Long-Term Assets | 17.9 | 12.82 | 25.23 | - | - | - |
Total Assets | 223.49 | 258.54 | 229.66 | 181.04 | 187.79 | 211.79 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 23.99 | 2.45 | 6.55 | 3.71 | 4.44 | 4.98 |
Current Portion of Leases | - | 3.55 | 4.53 | 4.04 | 3.7 | 4.11 |
Other Current Liabilities | - | 28.14 | 19.03 | 17.57 | 13.85 | 13.47 |
Total Current Liabilities | 23.99 | 34.14 | 30.11 | 25.32 | 22 | 22.55 |
Long-Term Leases | 16.81 | 19.44 | 5.51 | 9.01 | 11.62 | 14.47 |
Other Long-Term Liabilities | - | - | - | 0.07 | - | - |
Total Long-Term Liabilities | 16.81 | 19.44 | 5.51 | 9.08 | 11.62 | 14.47 |
Total Liabilities | 40.8 | 53.58 | 35.62 | 34.4 | 33.62 | 37.02 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1.55 | 1.54 | 1.54 | 1.54 | 1.54 | 1.54 |
Additional Paid-in Capital | 320.98 | 318.03 | 314.72 | 312.14 | 309.1 | 305.75 |
Retained Earnings | -139.83 | -114.62 | -122.21 | -167.05 | -156.48 | -132.53 |
Shareholders' Equity | 182.7 | 204.96 | 194.05 | 146.64 | 154.17 | 174.77 |
Total Liabilities & Equity | 223.49 | 258.54 | 229.66 | 181.04 | 187.79 | 211.79 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 16.81 | 22.99 | 10.04 | 13.05 | 15.32 | 18.58 |
Net Cash (Debt) | 62.53 | 82.94 | 74.7 | 74.59 | 66.28 | 96.35 |
Net Cash Growth | -18.89% | 11.03% | 0.14% | 12.55% | -31.21% | -29.00% |
Net Cash Per Share | 4.04 | 5.36 | 4.74 | 4.84 | 4.04 | 5.96 |
Book Value | 182.7 | 204.96 | 194.05 | 146.64 | 154.17 | 174.77 |
Book Value Per Share | 11.80 | 13.23 | 12.31 | 9.51 | 9.41 | 10.82 |
Tangible Book Value | 178.16 | 169.12 | 165.59 | 125.48 | 127.35 | 149.76 |
Tangible Book Value Per Share | 11.51 | 10.92 | 10.51 | 8.14 | 7.77 | 9.27 |